Average Co-Inventor Count = 5.73
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-Myers Squibb Compnay (18 from 3,685 patents)
2. Bristol-Myers Squibb Pharma Company (1 from 234 patents)
19 patents:
1. 10112941 - Tricyclic compounds as anticancer agents
2. 10106559 - Substituted tetrahydrocarbazole and carbazole carboxamide compounds
3. 9751879 - Tricyclic compounds as anticancer agents
4. 9725449 - Tricyclic compounds as anticancer agents
5. 9714234 - Carbazole carboxamide compounds
6. 9492460 - Carbazole compounds useful as bromodomain inhibitors
7. 9458156 - Tricyclic compounds as anticancer agents
8. 9334290 - Substituted tetrahydrocarbazole and carbazole carboxamide compounds
9. 9273014 - Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof
10. 9242941 - Alkyl, fluoroalkyl-1,4-benzodiazepinone compounds
11. 9133139 - Fluoroalkyl-1,4-benzodiazepinone compounds
12. 8999918 - Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof
13. 8685969 - Carboline carboxamide compounds useful as kinase inhibitors
14. 8362065 - Carbazole carboxamide compounds useful as kinase inhibitors
15. 8084620 - Carbazole carboxamide compounds useful as kinase inhibitors